000504 南华生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资2,692-50.30%5,4165,4845,9756,299
投资性房地产0--0000
固定资产13,967-2.21%14,28220,36216,50911,595
在建工程0--001,2860
无形资产413-6.35%4413612181,544
商誉1,9830.00%1,9838,4418,44111,231
其他非流动资产88,298-6.47%94,410102,481110,19345,771
107,353-7.88%116,531137,130142,62276,439

流动资产
货币资金204,540-58.58%493,811218,148153,00567,038
应收账款124,6351.15%123,224158,759196,119188,791
存货18,44473.02%10,6604,50110,64014,931
其他流动资产124,592358.82%27,15534,828156,860208,941
472,210-27.89%654,851416,236516,623479,701

流动负债
短期借款0-100.00%28,11763,08332,91013,015
应付票据0--0000
应付帐款80,414-2.19%82,21382,03289,56260,692
其他流动负债194,124-43.25%342,068310,037406,531344,554
274,538-39.31%452,397455,152529,002418,261
流动资产净值197,673-2.36%202,454(38,916)(12,379)61,439
资产总额减流动负债305,025-4.38%318,98698,215130,243137,879

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债12,231-14.54%14,31218,02919,9243,397
12,231-14.54%14,31218,02919,9243,397

总权益
    实收股本330,0230.00%330,023311,574311,574311,574
    储备项目(81,475)11.48%(73,082)(297,565)(294,934)(285,005)
股东权益248,548-3.27%256,94114,00916,64026,569
非控股权益44,246-7.31%47,73366,17793,679107,913